DOI: 10.1055/s-00050348

Indian Journal of Medical and Paediatric Oncology

References

Yeh CN, Chen MH, Chen YY, Yang CY, Yen CC, Tzen CY. et al.
A phase II trial of regorafenib in patients with metastatic and/or a unresectable gastrointestinal stromal tumor harboring secondary mutations of exon 17.

Oncotarget 2017;
8: 44121-30

Download Bibliographical Data

Access:
Access: